Today's Challenges. Tomorrow's Solutions.

Strategic Solutions for Pediatric Groups That Turn Every Well-Child Visit Into Durable Margin

Pediatric economics are built on volume, vaccines, and a Medicaid-heavy payer mix — a model with thin margins and little room for error. Fulcrum Health Partners advises independent practices, multisite groups, and PE-backed pediatric platforms across commercial rate strategy, Medicaid and CHIP managed-care negotiations, vaccine-administration and screening-code capture, and capitated, value-based models. We convert the panel you already see into reimbursement you can defend.

Model Your Reimbursement Opportunity → Speak with a Pediatric Advisor

$2.7B

Reimbursement Opportunity Identified

12,500+

Payer Contracts Reviewed

States Served

350+

Client Engagements

~50%

Of pediatric lives covered by Medicaid or CHIP

15+

Well-child visits recommended in the first three years

VFC

Supplies vaccine product; administration fees drive revenue

96110

Developmental screening — routinely under-billed

The Pediatric Reimbursement Landscape

High volume, low procedural revenue, and a payer mix nobody else has to manage.

Pediatrics runs on well-child visits and immunizations — not procedures — so margin is decided by the rates you negotiate, the vaccine economics you manage, and the screening codes you actually bill.

Well-child visits and E&M anchor the practice, but the money moves at the edges. Vaccine administration fees — not the product, which the Vaccines for Children program supplies for eligible patients — are a primary revenue lever, while commercial buy-and-stock vaccine purchasing carries real inventory, spoilage, and carrying-cost risk against thin margins. At the same time, developmental, behavioral, and mental-health screening codes are systematically under-billed, leaving earned revenue uncaptured on visits you are already performing.

Because Medicaid and CHIP make up roughly half of the pediatric payer mix, Medicaid managed-care rates and capitation are decisive — a few points of commercial uplift or a single renegotiated Medicaid MCO contract can outweigh a year of added volume. As capitation and PMPM models spread and pediatric MSOs consolidate the market, the same panel can be worth dramatically different amounts depending on how it is coded, contracted, and risk-managed. That is precisely where Fulcrum works.

Illustrative composition. Replace with your confirmed figures before launch; reflects current Medicaid, CHIP, VFC, and public payer methodology, 2024–2026.

Revenue Per Pediatric Patient — Illustrative

Where pediatric margin is left uncaptured

Well-child & E&M visits

Vaccine administration

Developmental & behavioral screening

Commercial rate uplift

The visit is the floor. Fulcrum quantifies the full stack — vaccine admin, under-billed screening, and commercial rate — against a Medicaid-weighted mix.

Reimbursement Intelligence in Action

Your pediatric economics, by practice profile

Fulcrum turns your claims, attribution, and contract data into executive dashboards. Select a profile to explore a sample payer-mix and revenue view spanning fee-for-service, vaccine administration, screening, and value-based revenue.

Independent Pediatric Practice · Payer Mix & Revenue Live Sample

Payer Mix (by attributed lives)

Net Revenue by Payer — Fee-for-Service vs. Vaccine, Screening & Value-Based

Fee-for-service net paymentsVaccine admin, screening & value-based revenue

Illustrative sample dashboard. Fulcrum builds these from your practice-management, claims, attribution, and contract data by CPT, payer, and contract.

Our Pediatric Advisory Solutions

Advisory organized around the economics you manage

Not a service menu — the reimbursement problems that decide pediatric margin and enterprise value, and the strategy, analytics, and negotiation capabilities that resolve them.

01 The Challenge — You can't negotiate what you haven't benchmarked

Contract Assessment & Reimbursement Benchmarking

We digitize and normalize every commercial, Medicaid MCO, and CHIP contract and fee schedule, then benchmark your pediatric reimbursement — including vaccine-administration and screening codes — against Medicare and against market, quantifying exactly where you sit and what the opportunity is worth.

Contract digitization

Fee schedule normalization

% of Medicare benchmarking

Vaccine-admin & screening rate analysis

Medicaid MCO & CHIP comparison

EOB & payment variance analysis

Underpayment identification

Revenue opportunity quantification

Contract performance scoring

02 The Challenge — Little leverage one contract at a time

Managed Care Negotiations & Strategy

We build the positioning, data, and strategy to improve commercial rates, vaccine-administration terms, and Medicaid managed-care and capitation economics across every payer — from renewals to executive payer meetings.

Commercial rate improvement

Medicaid MCO & CHIP terms

Vaccine-admin fee negotiation

Capitation & PMPM strategy

Escalation & executive strategy

Network participation strategy

03 The Challenge — Decisions made without modeling the downside

Contract Modeling & Analytics

CPT- and payer-level modeling that turns claims and contracts into scenario analysis, revenue forecasts, and side-by-side contract comparisons — including buy-and-stock vaccine margin and carrying cost — that your executives can act on.

CPT-level reimbursement modeling

Scenario & what-if analysis

Payer mix & revenue forecasting

Vaccine buy-and-stock margin modeling

Capitation vs. FFS modeling

Executive Power BI dashboards

04 The Challenge — Negotiating blind to what competitors are paid

Payer Transparency & Market Rate Intelligence

Federal Transparency in Coverage data has transformed the negotiating table. We mine machine-readable rate files to show what competing pediatric groups are actually paid for well-child, E&M, and vaccine codes — and arm your team with it.

Transparency in Coverage analysis

Competitor rate benchmarking

Market rate positioning

Negotiation preparation

Peer comparison

Commercial opportunity sizing

05 The Challenge — Effort spread evenly across unequal payers

Covered Lives & Market Intelligence

We map covered lives, Medicaid and CHIP penetration, attribution, and network adequacy across your market so you prioritize the negotiations and value-based opportunities that move the most pediatric margin.

Covered-lives analysis

Medicaid & CHIP penetration

Attribution & referral dynamics

Network adequacy leverage

Birth-rate & population trends

Commercial opportunity identification

06 The Challenge — Contract terms that aren't honored

Payer / Provider Disputes & Enforcement

When payers misinterpret terms, downcode well-child or screening claims, deny vaccine-administration fees, or delay, we lead the interpretation, escalation, and enforcement — turning contractual entitlement into collected revenue.

Contract interpretation

Payment & claims disputes

Downcoding & policy challenges

Escalation support

Executive negotiation

Contract enforcement

07 The Challenge — Earned revenue that never arrives

Underpayment / Overpayment Recovery & Revenue Integrity

Our analytics compare contracts, fee schedules, allowables, and EOB/remittance data to detect variances in both directions, quantify recoverable revenue, resolve overpayment exposure, and fix the root cause so leakage stops.

Contract compliance auditing

Underpayment & variance detection

Overpayment exposure review

Automated EOB/remit analytics

Recovery & appeals strategy

Revenue integrity programs

The Forces Reshaping Pediatric Economics

The strategic questions every pediatric leader now faces

Beyond the visit, these are the dynamics that decide pediatric margin — and where Fulcrum builds the strategy.

Medicaid & CHIP Rate Dependence

Managing a payer mix where Medicaid and CHIP dominate, and where managed-care rates and capitation — not commercial volume — decide the P&L.

The Vaccine Economy

Maximizing administration fees while managing commercial buy-and-stock inventory, spoilage, and carrying cost against thin margins, alongside the VFC program.

Under-Billed Screening

Capturing developmental, behavioral, and mental-health screening revenue on visits already performed — routinely missed against rising demand.

Capitation, PMPM & Value-Based Pediatrics

Deciding how much risk to take, and on what terms, as capitated and PMPM pediatric models expand across Medicaid managed care.

Prior Authorization & Administrative Burden

Reducing the administrative tax on referrals, imaging, and specialty medications as CMS prior-authorization reforms reshape payer obligations.

Consolidation: Pediatric MSO & Aggregation

Competing with — and evaluating alignment against — emerging pediatric MSOs and PE-backed platforms now consolidating a historically fragmented market.

Pediatric Reimbursement Calculator

See what optimized reimbursement is worth

Model the annual uplift from moving your commercial rates toward market and optimized levels — expressed as a percentage of Medicare — and add the revenue recoverable from fuller vaccine-administration and developmental / behavioral screening capture.

Your inputs

Enter approximate figures — nothing is stored or transmitted.

Annual commercial fee-for-service revenue

Current commercial rate (% of Medicare)

Optimized commercial rate (% of Medicare) — 120%

Annual vaccine-administration & screening capture recovery

Estimated annual reimbursement uplift

Adjust the inputs to model your opportunity.

Per $1M of commercial revenue

3-year cumulative

Directional estimate for discussion only. Combines commercial fee-for-service rate improvement with recoverable vaccine-administration and developmental / behavioral screening revenue; Medicaid managed-care and capitated value-based revenue are additive. A Fulcrum analysis models your actual contracts and payer mix.

Client Outcomes

How Fulcrum helps — and what it's worth

Anonymized outcomes from Fulcrum engagements with pediatric practices, groups, and platforms.

Independent Pediatric Practice

16%

commercial rate improvement

Situation: Benchmarking showed commercial rates well below market on well-child and E&M codes, with no leverage in prior renewals. Result: We repositioned the practice and renegotiated its top commercial payers, lifting blended commercial reimbursement without adding a single visit.

Multisite Pediatric Group

$1.9M

vaccine-admin & screening capture

Situation: Vaccine-administration fees were under-billed and developmental and behavioral screening codes were rarely captured across sites. Result: We rebuilt coding and charge capture and corrected payer denials — converting visits already performed into recurring revenue.

Pediatric MSO / PE Platform

8 pts

margin from contract harmonization

Situation: A multi-state platform carried a patchwork of legacy commercial and Medicaid MCO contracts with systematic underpayments. Result: We harmonized terms and recovered leakage, lifting EBITDA ahead of a recapitalization.

Why Pediatric Leaders Choose Fulcrum

The advisor that speaks pediatrics' economic language

Independent by design and fluent in the economics of the pediatric practice — well-child and E&M, vaccine administration, screening capture, Medicaid managed care, and capitated, value-based models — delivered by the people who do the work.

Independent Advisor

No networks, no downstream fees — only your economics.

Pediatric Fluency

Fluent in well-child, vaccine, and Medicaid economics.

Commercial Rate Benchmarking

Market and transparency data behind every ask.

Vaccine & Screening Analytics

Modeling down to the admin fee and screening code.

National Payer Experience

Insight into Medicaid and commercial policy in every market.

Capitation & Value-Based Insight

Positioning for PMPM and risk in Medicaid managed care.

Negotiation Leadership

Senior advisors at the table, not junior staff.

Data-Driven Support

Dashboards and intelligence that clarify the path.

Fulcrum Intelligence

Pediatric insights & analysis

Executive briefings on the forces moving pediatric economics — Medicaid and CHIP managed care, the vaccine economy, under-billed screening, capitation, and consolidation.

The Vaccine Economy: Admin Fees vs. Buy-and-Stock Risk → Capturing Developmental & Behavioral Screening Revenue →

Explore Pediatric Insights →